医学
肺
组织细胞
朗格汉斯细胞组织细胞增多症
呼吸系统
组织细胞增多症
克拉屈滨
病理
呼吸衰竭
肺功能测试
内科学
免疫学
肿瘤
细胞
朗格汉斯细胞
呼吸道疾病
突变
癌症研究
肿瘤科
激酶
作者
Sergio Harari,Robert Vassallo
出处
期刊:The European respiratory journal
[European Respiratory Society]
日期:2026-05-01
卷期号:67 (5): 2600040-2600040
标识
DOI:10.1183/13993003.00040-2026
摘要
Extract Adult pulmonary Langerhans cell histiocytosis (PLCH) is a distinct histiocytic neoplasm driven by activating mutations in the mitogen-activated protein kinase (MAPK) pathway, most commonly BRAFV600E [1]. The clinical course is highly heterogeneous, ranging from spontaneous stabilisation or remission, particularly after smoking cessation, to relentless decline in lung function, respiratory failure and premature death [2–4]. How best to treat progressive PLCH when lung function deteriorates despite smoking cessation remains a major unanswered question.
科研通智能强力驱动
Strongly Powered by AbleSci AI